Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonist
Crossref DOI link: https://doi.org/10.1007/s10928-015-9450-0
Published Online: 2015-10-18
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ogungbenro, Kayode
Hulme, Sharon
Rothwell, Nancy
Hopkins, Stephen
Tyrrell, Pippa
Galea, James
Text and Data Mining valid from 2015-10-18